首页> 外文期刊>British Journal of Radiology >Radical radiotherapy for early laryngeal cancer in a patient with human immunodeficiency virus: no evidence of increased toxicity.
【24h】

Radical radiotherapy for early laryngeal cancer in a patient with human immunodeficiency virus: no evidence of increased toxicity.

机译:人类免疫缺陷病毒患者的早期喉癌根治性放射疗法:无增加毒性的证据。

获取原文
获取原文并翻译 | 示例
           

摘要

There are very few reported cases of laryngeal squamous cell carcinoma (SCC) in patients with a background of human immunodeficiency virus (HIV) infection. We report a case of a 42-year-old man who developed a T2 N0 left vocal cord well differentiated SCC with an 11 year history of HIV infection. He successfully completed a course of radical radiotherapy 66 Gy in 33 fractions over 47 days. During his treatment he experienced only a grade 1 Radiation Therapy Oncology Group (RTOG) acute toxicity reaction to the larynx and no weight loss. At 32 months follow up he remains disease free and has no significant late morbidity. Prior to his radiotherapy his CD4 count was 350 cells mm(-3); we discuss the view that the treatment chosen needs to be individually tailored with respect to the patient's immune status.
机译:在具有人类免疫缺陷病毒(HIV)感染背景的患者中,报道的喉鳞状细胞癌(SCC)病例很少。我们报告了一例42岁的男性,该男性发展为T2 N0左声带,分化良好的SCC具有11年的HIV感染史。他在47天内成功地以33个分数成功完成了66 Gy的放射治疗。在治疗期间,他仅对喉部经历了1级放射治疗肿瘤学组(RTOG)急性毒性反应,并且没有体重减轻。在32个月的随访中,他没有疾病,也没有明显的晚期发病。在进行放射治疗之前,他的CD4计数为350细胞mm(-3);我们讨论的观点是,所选的治疗方法需要针对患者的免疫状况进行个性化定制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号